# clm_C2FCE96BEF20

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_equity  
value: 410,506,000 United States dollar  
valid_from: 2009-06-30  
valid_to: 2009-09-30  
published: 2010-07-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_1E23E8E53794  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total equity: 410,506,000 United States dollar", as of 2009-06-30 (until 2009-09-30). Claim clm_C2FCE96BEF20, https://asof.is/claim/clm_C2FCE96BEF20, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q2 FY2010, filed 2010-07-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm (primary, SEC EDGAR 10-Q Q2 FY2010, published 2010-07-28)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 421,514,000 United States dollar | valid 2008-12-31 to 2009-06-30 | conf 0.95 | superseded | superseded_by [clm_C2FCE96BEF20](/claim/clm_C2FCE96BEF20.md) | [clm_27270E64C661](/claim/clm_27270E64C661.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.